Status:
COMPLETED
The Effectiveness of Conversational AI Service (chatbot) Utilization on Vaccine Confidence
Lead Sponsor:
The University of Hong Kong
Collaborating Sponsors:
National University of Singapore
Health Intervention and Technology Assessment Program (HITAP)
Conditions:
Vaccination Hesitancy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary objective of this study is to develop and evaluate a conversational AI service (chatbot) on social media platforms to obtain accurate and up-to-date vaccine information, and assess the imp...
Detailed Description
The investigators will focus on vulnerable seniors and/or children from Hong Kong, Singapore and Thailand who have refused or delayed COVID-19 vaccination. Participants will be recruited by an online ...
Eligibility Criteria
Inclusion
- Hong Kong adult residents (English or Chinese users) with (a) unvaccinated senior parents/grandparents aged 60 (including those who received first dose after the announcement of the COVID passport on 4th of January) or (b) unvaccinated children aged below 18.
- Thailand adult residents (Thai users) with (a) unvaccinated senior parents/grandparents aged 60 or above or (b) unvaccinated children aged below 18.
- Singapore adult residents (English or Chinese users) with unvaccinated children aged between 5 to 11 years old.
Exclusion
- People who do not meet the inclusion criteria.
Key Trial Info
Start Date :
February 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 17 2023
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05424952
Start Date
February 11 2022
End Date
February 17 2023
Last Update
December 6 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Hong Kong
Hong Kong, Hong Kong
2
National University of Singapore
Singapore, Singapore
3
Health Intervention and Technology Assessment Program
Bangkok, Thailand